Cargando…
Serum biomarkers of inflammation and adiposity in the LABS cohort: associations with metabolic disease and surgical outcomes
BACKGROUND: The utility of serum biomarkers related to inflammation and adiposity as predictors of metabolic disease prevalence and outcomes after bariatric surgery are not well-defined. METHODS: Associations between pre- and post-operative serum levels of four biomarkers (C-reactive protein (CRP),...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240401/ https://www.ncbi.nlm.nih.gov/pubmed/29777230 http://dx.doi.org/10.1038/s41366-018-0088-z |
_version_ | 1783371626442653696 |
---|---|
author | O’Rourke, Robert W. Johnson, Geoffrey S. Purnell, Jonathan Q. Courcoulas, Anita P. Dakin, Gregory F. Garcia, Luis Hinojosa, Marcelo Mitchell, James E. Pomp, Alfons Pories, Walter J. Spaniolas, Konstantinos Flum, David R. Wahed, Abdus S. Wolfe, Bruce M. |
author_facet | O’Rourke, Robert W. Johnson, Geoffrey S. Purnell, Jonathan Q. Courcoulas, Anita P. Dakin, Gregory F. Garcia, Luis Hinojosa, Marcelo Mitchell, James E. Pomp, Alfons Pories, Walter J. Spaniolas, Konstantinos Flum, David R. Wahed, Abdus S. Wolfe, Bruce M. |
author_sort | O’Rourke, Robert W. |
collection | PubMed |
description | BACKGROUND: The utility of serum biomarkers related to inflammation and adiposity as predictors of metabolic disease prevalence and outcomes after bariatric surgery are not well-defined. METHODS: Associations between pre- and post-operative serum levels of four biomarkers (C-reactive protein (CRP), cystatin C (CC), leptin, ghrelin) with baseline measures of adiposity and metabolic disease prevalence (asthma, diabetes, sleep apnea), and weight loss and metabolic disease remission after bariatric surgery were studied in the Longitudinal Assessment of Bariatric Surgery (LABS) cohort. RESULTS: Baseline CRP levels were positively associated with the odds of asthma but not diabetes or sleep apnea; baseline CC levels were positively associated with asthma, diabetes, and sleep apnea; baseline leptin levels were positively associated with asthma and negatively associated with diabetes and sleep apnea; baseline ghrelin levels were negatively associated with diabetes and sleep apnea. Increased weight loss was associated with increased baseline levels of leptin and CRP and decreased baseline levels of CC. Remission of diabetes and asthma was not associated with baseline levels of any biomarker. A higher likelihood of asthma remission was associated with a greater decrease in leptin levels, and a higher likelihood of diabetes remission was predicted by a lesser decrease in CC. Bariatric surgery was associated with decreased post-operative CC, CRP, and leptin levels, and increased post-operative ghrelin levels. CONCLUSION: This is the largest study to date of serum biomarkers of inflammation and adiposity in a bariatric surgery cohort. Biomarker levels correlate with metabolic disease prevalence prior to bariatric surgery, and with weight loss but not metabolic disease remission after surgery. Bariatric surgery regulates serum biomarker levels in a manner consistent with anti-inflammatory and compensatory orexigenic effects. These data contribute to our understanding of the mechanisms underlying the biologic effects of bariatric surgery. |
format | Online Article Text |
id | pubmed-6240401 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
record_format | MEDLINE/PubMed |
spelling | pubmed-62404012018-11-18 Serum biomarkers of inflammation and adiposity in the LABS cohort: associations with metabolic disease and surgical outcomes O’Rourke, Robert W. Johnson, Geoffrey S. Purnell, Jonathan Q. Courcoulas, Anita P. Dakin, Gregory F. Garcia, Luis Hinojosa, Marcelo Mitchell, James E. Pomp, Alfons Pories, Walter J. Spaniolas, Konstantinos Flum, David R. Wahed, Abdus S. Wolfe, Bruce M. Int J Obes (Lond) Article BACKGROUND: The utility of serum biomarkers related to inflammation and adiposity as predictors of metabolic disease prevalence and outcomes after bariatric surgery are not well-defined. METHODS: Associations between pre- and post-operative serum levels of four biomarkers (C-reactive protein (CRP), cystatin C (CC), leptin, ghrelin) with baseline measures of adiposity and metabolic disease prevalence (asthma, diabetes, sleep apnea), and weight loss and metabolic disease remission after bariatric surgery were studied in the Longitudinal Assessment of Bariatric Surgery (LABS) cohort. RESULTS: Baseline CRP levels were positively associated with the odds of asthma but not diabetes or sleep apnea; baseline CC levels were positively associated with asthma, diabetes, and sleep apnea; baseline leptin levels were positively associated with asthma and negatively associated with diabetes and sleep apnea; baseline ghrelin levels were negatively associated with diabetes and sleep apnea. Increased weight loss was associated with increased baseline levels of leptin and CRP and decreased baseline levels of CC. Remission of diabetes and asthma was not associated with baseline levels of any biomarker. A higher likelihood of asthma remission was associated with a greater decrease in leptin levels, and a higher likelihood of diabetes remission was predicted by a lesser decrease in CC. Bariatric surgery was associated with decreased post-operative CC, CRP, and leptin levels, and increased post-operative ghrelin levels. CONCLUSION: This is the largest study to date of serum biomarkers of inflammation and adiposity in a bariatric surgery cohort. Biomarker levels correlate with metabolic disease prevalence prior to bariatric surgery, and with weight loss but not metabolic disease remission after surgery. Bariatric surgery regulates serum biomarker levels in a manner consistent with anti-inflammatory and compensatory orexigenic effects. These data contribute to our understanding of the mechanisms underlying the biologic effects of bariatric surgery. 2018-05-17 2019-02 /pmc/articles/PMC6240401/ /pubmed/29777230 http://dx.doi.org/10.1038/s41366-018-0088-z Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article O’Rourke, Robert W. Johnson, Geoffrey S. Purnell, Jonathan Q. Courcoulas, Anita P. Dakin, Gregory F. Garcia, Luis Hinojosa, Marcelo Mitchell, James E. Pomp, Alfons Pories, Walter J. Spaniolas, Konstantinos Flum, David R. Wahed, Abdus S. Wolfe, Bruce M. Serum biomarkers of inflammation and adiposity in the LABS cohort: associations with metabolic disease and surgical outcomes |
title | Serum biomarkers of inflammation and adiposity in the LABS cohort: associations with metabolic disease and surgical outcomes |
title_full | Serum biomarkers of inflammation and adiposity in the LABS cohort: associations with metabolic disease and surgical outcomes |
title_fullStr | Serum biomarkers of inflammation and adiposity in the LABS cohort: associations with metabolic disease and surgical outcomes |
title_full_unstemmed | Serum biomarkers of inflammation and adiposity in the LABS cohort: associations with metabolic disease and surgical outcomes |
title_short | Serum biomarkers of inflammation and adiposity in the LABS cohort: associations with metabolic disease and surgical outcomes |
title_sort | serum biomarkers of inflammation and adiposity in the labs cohort: associations with metabolic disease and surgical outcomes |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240401/ https://www.ncbi.nlm.nih.gov/pubmed/29777230 http://dx.doi.org/10.1038/s41366-018-0088-z |
work_keys_str_mv | AT orourkerobertw serumbiomarkersofinflammationandadiposityinthelabscohortassociationswithmetabolicdiseaseandsurgicaloutcomes AT johnsongeoffreys serumbiomarkersofinflammationandadiposityinthelabscohortassociationswithmetabolicdiseaseandsurgicaloutcomes AT purnelljonathanq serumbiomarkersofinflammationandadiposityinthelabscohortassociationswithmetabolicdiseaseandsurgicaloutcomes AT courcoulasanitap serumbiomarkersofinflammationandadiposityinthelabscohortassociationswithmetabolicdiseaseandsurgicaloutcomes AT dakingregoryf serumbiomarkersofinflammationandadiposityinthelabscohortassociationswithmetabolicdiseaseandsurgicaloutcomes AT garcialuis serumbiomarkersofinflammationandadiposityinthelabscohortassociationswithmetabolicdiseaseandsurgicaloutcomes AT hinojosamarcelo serumbiomarkersofinflammationandadiposityinthelabscohortassociationswithmetabolicdiseaseandsurgicaloutcomes AT mitchelljamese serumbiomarkersofinflammationandadiposityinthelabscohortassociationswithmetabolicdiseaseandsurgicaloutcomes AT pompalfons serumbiomarkersofinflammationandadiposityinthelabscohortassociationswithmetabolicdiseaseandsurgicaloutcomes AT porieswalterj serumbiomarkersofinflammationandadiposityinthelabscohortassociationswithmetabolicdiseaseandsurgicaloutcomes AT spaniolaskonstantinos serumbiomarkersofinflammationandadiposityinthelabscohortassociationswithmetabolicdiseaseandsurgicaloutcomes AT flumdavidr serumbiomarkersofinflammationandadiposityinthelabscohortassociationswithmetabolicdiseaseandsurgicaloutcomes AT wahedabduss serumbiomarkersofinflammationandadiposityinthelabscohortassociationswithmetabolicdiseaseandsurgicaloutcomes AT wolfebrucem serumbiomarkersofinflammationandadiposityinthelabscohortassociationswithmetabolicdiseaseandsurgicaloutcomes |